Bill J. Smith

937 total citations
25 papers, 636 citations indexed

About

Bill J. Smith is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Bill J. Smith has authored 25 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Bill J. Smith's work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and HIV Research and Treatment (4 papers). Bill J. Smith is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and HIV Research and Treatment (4 papers). Bill J. Smith collaborates with scholars based in United States, United Kingdom and China. Bill J. Smith's co-authors include Victor I. Reus, Bernard P. Murray, I.G. Sipes, Megan Gibbs, James G. Christensen, Aaron H. Burstein, Hélène M. Faessel, Helen Y. Zou, David J. Clark and Shinji Yamazaki and has published in prestigious journals such as The FASEB Journal, Journal of Pharmacology and Experimental Therapeutics and Carcinogenesis.

In The Last Decade

Bill J. Smith

25 papers receiving 613 citations

Peers

Bill J. Smith

PHARM

ONCOL

PHYSI

PRM

Tessa M. Bosch Netherlands

L. Giuliani Italy

Lisa St. John‐Williams United States

Sang Seop Lee South Korea

Dandan Wang China

Catherine Spire France

N.R. Kitteringham United Kingdom

Nigel McCracken United States

Yuko Makino Japan

Tessa M. Bosch Netherlands

Bill J. Smith

278 ×1.1

186 ×1.2

PHARM

411 ×2.9

ONCOL

38 ×0.4

PHYSI

77 ×1.0

PRM

Citations per year, relative to Bill J. Smith Bill J. Smith (= 1×) peers Tessa M. Bosch

Countries citing papers authored by Bill J. Smith

Since Specialization

Citations

This map shows the geographic impact of Bill J. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bill J. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bill J. Smith more than expected).

Fields of papers citing papers by Bill J. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bill J. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bill J. Smith. The network helps show where Bill J. Smith may publish in the future.

Co-authorship network of co-authors of Bill J. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Bill J. Smith. A scholar is included among the top collaborators of Bill J. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bill J. Smith. Bill J. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Jim, Bing Lu, Gavin Carr, et al.. (2024). Lenacapavir Exhibits Atropisomerism—Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance Pathway. Journal of Pharmacology and Experimental Therapeutics. 391(1). 91–103. 6 indexed citations

Singh, Dilip Kumar, S. Cyrus Khojasteh, Bernard P. Murray, et al.. (2023). Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs. Drug Metabolism and Disposition. 51(10). 1362–1371. 6 indexed citations

Subramanian, Raju, John Ling, Jianhong Wang, et al.. (2022). Human and nonclinical disposition of [¹⁴C]bictegravir, a potent integrase strand-transfer inhibitor for the treatment of HIV-1 infection. Xenobiotica. 52(9-11). 973–985. 4 indexed citations

Subramanian, Raju, Jianhong Wang, Bernard P. Murray, et al.. (2022). Human pharmacokinetics prediction with an in vitro–in vivo correction factor approach and in vitro drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy^® for the treatment of HIV-1 infection. Xenobiotica. 52(12). 1020–1030. 3 indexed citations

Pitts, Jared, Darius Babusis, Meghan S. Vermillion, et al.. (2022). Intravenous delivery of GS-441524 is efficacious in the African green monkey model of SARS-CoV-2 infection. Antiviral Research. 203. 105329–105329. 5 indexed citations

Le, Hoa Thi, Jennifer Tang, Jingyu Zhang, et al.. (2022). ¹⁸O-Enabled High-Throughput Acyl Glucuronide Stability Assay. Chemical Research in Toxicology. 35(8). 1400–1409. 2 indexed citations

Basit, Abdul, Peter W. Fan, S. Cyrus Khojasteh, et al.. (2021). Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species. Drug Metabolism and Disposition. 50(3). 197–203. 23 indexed citations

Basit, Abdul, Albert P. Li, Peter W. Fan, et al.. (2020). Regional Proteomic Quantification of Clinically Relevant Non-Cytochrome P450 Enzymes along the Human Small Intestine. Drug Metabolism and Disposition. 48(7). 528–536. 28 indexed citations

Zheng, Jim, et al.. (2020). Characterization of Seasonal Pharmacokinetic Variability in Woodchucks. Drug Metabolism and Disposition. 48(11). 1199–1209. 1 indexed citations

10.

Zheng, Jim, Xin Yan, Jingyu Zhang, et al.. (2018). Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite—Resolution for Clinical Development. Drug Metabolism and Disposition. 46(3). 237–247. 40 indexed citations

11.

Zientek, Michael, Theunis C. Goosen, Elaine Tseng, et al.. (2015). In Vitro Kinetic Characterization of Axitinib Metabolism. Drug Metabolism and Disposition. 44(1). 102–114. 30 indexed citations

12.

Yamazaki, Shinji, Paolo Vicini, Zhongzhou Shen, et al.. (2011). Pharmacokinetic/Pharmacodynamic Modeling of Crizotinib for Anaplastic Lymphoma Kinase Inhibition and Antitumor Efficacy in Human Tumor Xenograft Mouse Models. Journal of Pharmacology and Experimental Therapeutics. 340(3). 549–557. 55 indexed citations

13.

Yamazaki, Shinji, David Romero, Joseph H. Lee, et al.. (2008). Pharmacokinetic-Pharmacodynamic Modeling of Biomarker Response and Tumor Growth Inhibition to an Orally Available cMet Kinase Inhibitor in Human Tumor Xenograft Mouse Models. Drug Metabolism and Disposition. 36(7). 1267–1274. 71 indexed citations

14.

Faessel, Hélène M., et al.. (2006). Single‐Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers. The Journal of Clinical Pharmacology. 46(9). 991–998. 86 indexed citations

15.

Smith, Bill J., et al.. (1999). Gas chromatographic–mass spectrometric analysis of hydroxylamine for monitoring the metabolic hydrolysis of metalloprotease inhibitors in rat and human liver microsomes. Journal of Chromatography B Biomedical Sciences and Applications. 724(1). 181–187. 29 indexed citations

16.

Smith, Bill J., et al.. (1998). Evaluation of the Effects of Risedronate on Hepatic Microsomal Drug Metabolizing Enzyme Activities Following Administration to Rats for 14 Days: Lack of an Induction Response. Drug and Chemical Toxicology. 21(3). 291–303. 3 indexed citations

17.

Hooser, Stephen B., et al.. (1995). Ovarian Toxicity of 4-Vinylcyclohexene and Related Olefins in B6C3F1 Mice: Role of Diepoxides. Chemical Research in Toxicology. 8(7). 963–969. 40 indexed citations

18.

Hughes, Michael F., Bill J. Smith, & Thomas E. Eling. (1992). The oxidation of 4-aminobiphenyl by horseradish peroxidase. Chemical Research in Toxicology. 5(3). 340–345. 15 indexed citations

19.

Smith, Bill J., I.G. Sipes, Jeffrey Stevens, & James R. Halpert. (1990). The biochemical basis for the species difference in hepatic microsomal 4-vinylcyclohexene epoxidation between female mice and rats. Carcinogenesis. 11(11). 1951–1957. 19 indexed citations

20.

Smith, Bill J., Dean E. Carter, & I.G. Sipes. (1990). Comparison of the disposition and in vitro metabolism of 4-vinylcyclohexene in the female mouse and rat. Toxicology and Applied Pharmacology. 105(3). 364–371. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact